# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BTIG analyst Ryan Zimmerman maintains Integra Lifesciences (NASDAQ:IART) with a Sell and lowers the price target from $22 to...
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and lowers the price target from $...
JMP Securities analyst David Turkaly maintains Integra Lifesciences (NASDAQ:IART) with a Market Outperform and lowers the pr...
Truist Securities analyst Richard Newitter maintains Integra Lifesciences (NASDAQ:IART) with a Hold and lowers the price tar...
Citigroup analyst Joanne Wuensch downgrades Integra Lifesciences (NASDAQ:IART) from Neutral to Sell and lowers the price tar...
BTIG analyst Ryan Zimmerman downgrades Integra Lifesciences (NASDAQ:IART) from Neutral to Sell and announces $22 price target.